Summary & Overview
HCPCS L8641: Metatarsal Joint Implant
HCPCS Level II code L8641 designates a metatarsal joint implant — a prosthetic device used in reconstructive foot surgery to replace or support the metatarsophalangeal joint. Nationally, device supply codes like L8641 are important for tracking device utilization, facility supply charges, and aligning implant supply reporting across payers and care settings.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context, typical site of service, and the types of benchmarks and policy considerations commonly associated with implant supply codes. The publication summarizes common modifier usage and payer coverage patterns where available, outlines reporting expectations for facility supply line items, and flags policy updates that typically affect supply reimbursement and prior authorization requirements.
This summary is intended to orient clinicians, billing professionals, and policymakers to the practical implications of L8641 for coding, billing, and administrative workflows related to metatarsal joint implant supplies in ambulatory and hospital outpatient settings.
Billing Code Overview
HCPCS Level II code L8641 describes a metatarsal joint implant, a prosthetic device used to replace or support the metatarsophalangeal joint in the foot. This code represents the supply of the implant itself rather than surgical procedures or physician services.
Service Type: Orthopedic implant/supply
Typical Site of Service: Hospital outpatient department or ambulatory surgery center (podiatric/orthopedic surgery setting)
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 62-year-old ambulatory patient with chronic metatarsalgia and symptomatic osteoarthritis of the first metatarsophalangeal and lesser metatarsal joints presents for surgical management after failing conservative care (orthotics, NSAIDs, corticosteroid injections). The orthopedic foot and ankle surgeon evaluates weight-bearing radiographs and confirms focal joint degeneration with pain localized to the metatarsal head and joint space. The planned procedure is placement of a L8641 metatarsal joint implant to restore joint alignment, relieve pain, and preserve motion.
Preoperative workflow includes medical clearance, informed consent documenting implant type L8641, pre-op imaging, and templating. Intraoperative workflow includes surgical exposure of the involved metatarsal joint, joint preparation, implant sizing and insertion, fluoroscopic confirmation, and closure. Postoperative workflow includes pain control, surgical dressing and immobilization, weight-bearing instructions or protected ambulation, physical therapy referral as indicated, and outpatient follow-up with radiographic assessment to document implant position and healing.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
62 | Two surgeons | When two surgeons of different specialties perform distinct portions of the operative procedure (e.g., complex reconstruction with assist). |